Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Debt (2016 - 2023)

Marimed (MRMD) has disclosed Total Debt for 12 consecutive years, with $22.5 million as the latest value for Q3 2023.

  • Quarterly Total Debt changed N/A to $22.5 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $22.5 million through Sep 2023, changed N/A year-over-year, with the annual reading at $17.3 million for FY2021, 45.79% up from the prior year.
  • Total Debt for Q3 2023 was $22.5 million at Marimed, down from $24.1 million in the prior quarter.
  • The five-year high for Total Debt was $24.1 million in Q2 2023, with the low at $46000.0 in Q1 2022.
  • Average Total Debt over 5 years is $8.9 million, with a median of $5.4 million recorded in 2020.
  • The sharpest move saw Total Debt tumbled 98.58% in 2022, then soared 52297.83% in 2023.
  • Over 5 years, Total Debt stood at $1.8 million in 2019, then skyrocketed by 574.76% to $11.8 million in 2020, then soared by 45.79% to $17.3 million in 2021, then tumbled by 99.73% to $46000.0 in 2022, then surged by 48802.17% to $22.5 million in 2023.
  • According to Business Quant data, Total Debt over the past three periods came in at $22.5 million, $24.1 million, and $24.1 million for Q3 2023, Q2 2023, and Q1 2023 respectively.